Background: Robotic surgery represents the most advanced evolution of minimally invasive colorectal procedures. The Hugo™ Robotic-Assisted Surgery (RAS) platform by Medtronic, introduced in 2021, is a novel modular system designed to enhance accessibility and flexibility. Evidence on its application in colorectal procedures remains limited. This study aimed to evaluate the perioperative outcomes of major colorectal resections performed using the Hugo™ RAS system. Methods: A retrospective, consecutive, single-center case series was conducted on all adult patients who underwent major colorectal surgery using the Hugo™ RAS platform between May 2024 and March 2025. Primary endpoints included operative time, docking time, conversions, and intraoperative complications. Secondary endpoints included postoperative complications (classified using Clavien–Dindo), length of stay, time to bowel function recovery, postoperative pain, and readmission. All perioperative variables were standardized with defined measurement criteria, and complication severity was systematically graded. Results: Forty-four patients were included. All surgeries were completed robotically without conversion or intraoperative complications. The median docking time was 11 min, the median console time was 179 min, and the median operative time was 300 min. Four patients (9.1%) developed major complications (Clavien–Dindo III). Right colectomy anastomoses were intracorporeal, performed with a laparoscopic linear stapler through the assistant port due to absence of a robotic stapler. Conclusions: Major colorectal resections performed with the Hugo™ RAS platform were feasible and safe, with satisfactory perioperative outcomes and no conversions. These findings confirm the reproducibility of this novel robotic system in colorectal surgery. Larger prospective multicenter studies with extended follow-up are warranted to further assess long-term and oncological outcomes.
Background: Recovery after intestinal stoma formation involves practical, psychological, social, and functional changes that may not evolve in parallel with patients’ overall perception of quality of life. This study examined patient-reported trajectories during the first six postoperative months and explored whether multidimensional stoma-related outcomes followed the same pattern as directly reported global quality of life. Methods: This prospective single-centre observational study included patients with complete assessments at approximately 2 weeks, 1 month, 3 months, and 6 months after ileostomy or colostomy formation. Patient responses were collected at each follow-up and subsequently manually transcribed into an electronic study database. The primary exploratory outcome was a corrected 30-component stoma-related patient-reported composite index (range 0–30; higher values more favourable) derived from an adapted, non-validated questionnaire. A direct 0–10 global quality-of-life item, which also contributed one component to the composite, was analysed separately. Longitudinal change was assessed using Friedman tests with Bonferroni-adjusted Wilcoxon signed-rank comparisons. Post hoc robustness analyses recomputed the composite after excluding the global quality-of-life component and after additionally excluding the sexual-activity components. Results: Our study included 23 patients. The median composite index increased from 9.4 (IQR 7.2–13.6) at 2 weeks to 10.9 (8.7–13.6) at 1 month and 12.2 (9.3–15.3) at 3 months and was 11.8 (9.3–17.2) at 6 months (Friedman chi-square(3) = 19.08, p < 0.001; Kendall’s W = 0.276). Bonferroni-adjusted comparisons were significant for 2 weeks versus 3 months (p = 0.037), 2 weeks versus 6 months (p = 0.016), and 1 month versus 6 months (p = 0.045). Median global quality-of-life ratings were 5, 6, 6, and 5, respectively, with no significant longitudinal change (p = 0.753). Excluding the global quality-of-life component from the composite produced a similar overall result (Friedman chi-square(3) = 19.38, p < 0.001). Conclusions: The exploratory composite showed statistically significant longitudinal change during the first six postoperative months, whereas directly reported global quality of life did not show a parallel change. Because the composite is non-validated and no threshold for clinically meaningful change has been established, these findings should not be interpreted as demonstrating clinically meaningful improvement in adaptation or quality of life. Rather, they suggest that several stoma-related patient-reported dimensions may change over time differently from global quality of life. These findings are exploratory and require confirmation in larger cohorts using validated patient-reported outcome measures.